https://www.pharmamanufacturing.com/industry-news/news/55411837/charles-river-to-provide-viral-safety-testing-for-magellans-stem-cell-therapy-candidatePharma Manufacturingen2026-10-14T15:51:37.000ZCharles River to provide viral safety testing for Magellan’s stem cell therapy candidatehttps://www.pharmamanufacturing.com/industry-news/news/55411827/scinai-secures-51m-services-agreement-with-us-nasdaq-listed-biopharma-companyPharma Manufacturingen2026-10-14T15:44:07.000ZScinai secures $5.1M services agreement with US, Nasdaq-listed biopharma companyhttps://www.pharmamanufacturing.com/industry-news/news/55411521/ucb-dedicates-site-for-2b-georgia-biologics-campusPharma Manufacturingen2026-10-13T15:51:19.000ZUCB dedicates site for $2B Georgia biologics campushttps://www.pharmamanufacturing.com/industry-news/news/55411519/catalent-to-make-mantras-single-dose-oral-gel-productsPharma Manufacturingen2026-10-13T15:49:45.000ZCatalent to make Mantra’s single-dose oral gel products